Search Results - Biwei Yang
- Showing 1 - 9 results of 9
-
1
-
2
-
3
-
4
-
5
Modeling cross‐talk of RNA modification enzymes reveals tumor microenvironment‐associated clinical significance and immunotherapy prediction in hepatobiliary malignancy by Feng Qi, Jia Li, Zhuoran Qi, Bin Zhou, Biwei Yang, Jun Zhang, Wenxing Qin
Published in MedComm (2023-06-01)Get full text
Article -
6
Comprehensive Metabolic Profiling and Genome-wide Analysis Reveal Therapeutic Modalities for Hepatocellular Carcinoma by Feng Qi, Jia Li, Zhuoran Qi, Jian Zhang, Bin Zhou, Biwei Yang, Wenxing Qin, Wenguo Cui, Jinglin Xia
Published in Research (2023-01-01)Get full text
Article -
7
Gelation embolism agents suppress clinical TACE-incited pro-metastatic microenvironment against hepatocellular carcinoma progressionResearch in context by Li Song, Chunyan Zhu, Qing Shi, Yuhan Xia, Xiayi Liang, Wen Qin, Tao Ye, Biwei Yang, Xin Cao, Jinglin Xia, Kun Zhang
Published in EBioMedicine (2024-11-01)Get full text
Article -
8
Tumor Mutation Burden-Associated LINC00638/miR-4732-3p/ULBP1 Axis Promotes Immune Escape via PD-L1 in Hepatocellular Carcinoma by Feng Qi, Feng Qi, Xiaojing Du, Xiaojing Du, Zhiying Zhao, Ding Zhang, Mengli Huang, Yuezong Bai, Biwei Yang, Wenxing Qin, Jinglin Xia, Jinglin Xia
Published in Frontiers in Oncology (2021-09-01)Get full text
Article -
9
Survival in patients with unresectable hepatocellular carcinoma: TCC cocktail plus TACE vs TACE alone prospective randomized clinical trial by Jie Li, Bei Lv, Li Song, Xingxing Zhang, Jian Zhang, Xiaoyi Ding, Yongqiang Liu, Tao Ye, Mengzhou Guo, Tingting Fang, Biwei Yang, Zhiying Zhao, Peixin Huang, Yi Chen, Ningling Ge, Jinglin Xia
Published in Journal of Translational Medicine (2025-07-01)Get full text
Article
